Accuray, Inc. manufactures image-guided radiosurgery devices. The Company is based in the United States and its core product, the CyberKnife Stereotactic Radiosurgery System, combines image-guidance with robotics to offer unparalleled flexibility and accuracy. Accuray's focus is to revolutionize the treatment of solid cancers throughout the body by the precise delivery of high doses of radiation using the CyberKnife Stereotactic Radiosurgery System.... (Source: SEC reports)
SUNNYVALE, Calif., Aug. 22, 2017 /PRNewswire/ --Â Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2017. Q4 [...]
SUNNYVALE, Calif., July 28, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) has entered into privately negotiated agreements with a limited number of existing holders of the company\'s outstanding convertible [...]
SUNNYVALE, Calif., July 17, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary revenue and product orders for the fourth quarter and full fiscal year ended [...]
SUNNYVALE, Calif., May 24, 2017 /PRNewswire/ --Â Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed, Stan Gee, who has been with Accuray for over eight years, to [...]